- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/08 - AntiepilepticsAnticonvulsants
Patent holdings for IPC class A61P 25/08
Total number of patents in this class: 2630
10-year publication summary
|
90
|
88
|
147
|
242
|
216
|
269
|
294
|
233
|
189
|
131
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 194 |
108 |
| Jazz Pharmaceuticals Research UK Limited | 217 |
67 |
| Taisho Pharmaceutical Co., Ltd. | 870 |
43 |
| Xenon Pharmaceuticals Inc. | 189 |
42 |
| The Regents of the University of California | 19868 |
38 |
| Takeda Pharmaceutical Company Limited | 2711 |
33 |
| Sage Therapeutics, Inc. | 363 |
32 |
| Zogenix International Limited | 76 |
30 |
| Katholieke Universiteit Leuven | 1187 |
27 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 177 |
25 |
| Hoffmann-La Roche Inc. | 3405 |
23 |
| Praxis Precision Medicines, Inc. | 175 |
23 |
| Janssen Pharmaceutica N.V. | 3399 |
22 |
| F. Hoffmann-La Roche AG | 7929 |
21 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
19 |
| The Johns Hopkins University | 5659 |
17 |
| Sumitomo Dainippon Pharma Co., Ltd. | 216 |
16 |
| Eisai R&D Management Co., Ltd. | 1238 |
15 |
| Sumitomo Pharma Co., Ltd. | 586 |
15 |
| Centre National de La Recherche Scientifique | 10414 |
14 |
| Other owners | 2000 |